THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,515,510 | -16.6% | 7,012,226 | 0.0% | 8.59% | -45.8% |
| Q2 2023 | $72,576,538 | -4.6% | 7,012,226 | 0.0% | 15.84% | -3.2% |
| Q1 2023 | $76,082,653 | -3.3% | 7,012,226 | 0.0% | 16.36% | +17.4% |
| Q4 2022 | $78,677,176 | +10.7% | 7,012,226 | 0.0% | 13.94% | -8.6% |
| Q3 2022 | $71,104,000 | +8.0% | 7,012,226 | -3.5% | 15.26% | +13.2% |
| Q2 2022 | $65,862,000 | -99.9% | 7,269,584 | 0.0% | 13.47% | +3.8% |
| Q1 2022 | $69,497,223,000 | +94504.2% | 7,269,584 | +9.3% | 12.98% | -18.4% |
| Q4 2021 | $73,461,000 | +101.4% | 6,648,025 | +34.9% | 15.90% | +96.8% |
| Q3 2021 | $36,478,000 | – | 4,929,423 | – | 8.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |